- Home
- NVVE vs XXII Comparison
NVVE vs XXII Comparison
Compare NVVE & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVVE | XXII |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 3.3M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | NVVE | XXII |
|---|---|---|
| Price | $0.86 | $4.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 201.1K | 36.3K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,832,530.00 |
| Revenue This Year | $892.33 | N/A |
| Revenue Next Year | N/A | $79.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.10 | $0.67 |
| 52 Week High | $5.69 | $11.37 |
Technical Indicators
Market Signals| Indicator | NVVE | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 44.40 |
| Support Level | $0.83 | $0.71 |
| Resistance Level | $1.13 | $6.86 |
| Average True Range (ATR) | 0.14 | 0.47 |
| MACD | 0.03 | -0.26 |
| Stochastic Oscillator | 14.16 | 16.89 |
Price Performance
Historical ComparisonAbout NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.